Trademark: 79102506
Word
IMMODULON THERAPEUTICS
Status Date
Friday, July 30, 2021
Registration Number
4307164
Registration Date
Tuesday, March 26, 2013
Filing Date
Friday, July 29, 2011
Published for Opposition
Tuesday, January 8, 2013
Cancellation Date
Friday, July 30, 2021
5 Vaccines; immune modulators, namely, pharmaceutical preparations for treatment of immune system related diseases, disorders, and dysregulation; vitamins and vitamin preparations
44 Medical and therapeutic services, namely, treatment of patients with immuno disorders; medical, hygienic and beauty care for human beings; provision of medical information; advisory services relating to medical services, preparations and apparatus, namely, providing medical information, consultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of health, namely, providing an on-line computer database featuring information regarding health and nutrition
42 Scientific and technological services and research and design relating thereto, namely, research and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research services, namely, research relating to immune system related diseases and disorders; clinical research in the field of medical science, namely, medical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biological products, medical apparatus, devices and instruments, namely, pharmaceutical drug development services; supply of information in the area of laboratory technology, namely, providing technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portals, namely, providing scientific information in the field of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; scientific consultancy, namely, consulting services in the field of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; consultancy and research in the fields of science and technology, namely, research in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic services, namely, laboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technology, namely, providing an on-line computer database in the field of medical and scientific research of immune dysregulation
The mark consists of the wording "IMMODULON THERAPEUTICS" to the right of a stylized ancient Greek or Roman woman with a partial display of an anchor.
Color is not claimed as a feature of the mark.
"THERAPEUTICS"
Feb 19, 2022
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Feb 19, 2022
Death Of International Registration
Sep 12, 2020
Total Invalidation Processed By The Ib
Aug 12, 2020
Total Invalidation Of Reg Ext Protection Sent To Ib
Aug 12, 2020
Invalidation Processed
Jul 1, 2020
Total Invalidation Of Reg Ext Protection Created
Nov 1, 2019
Cancelled Section 71
Mar 26, 2018
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jan 30, 2015
New Representative At Ib Received
Dec 24, 2013
Final Decision Transaction Processed By Ib
Dec 2, 2013
Final Disposition Notice Sent To Ib
Dec 2, 2013
Final Disposition Processed
Jun 26, 2013
Final Disposition Notice Created, To Be Sent To Ib
Mar 26, 2013
Registered-Principal Register
Jan 14, 2013
Notification Processed By Ib
Jan 8, 2013
Official Gazette Publication Confirmation E-Mailed
Jan 8, 2013
Published For Opposition
Dec 19, 2012
Notification Of Possible Opposition Sent To Ib
Dec 19, 2012
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 19, 2012
Notification Of Notice Of Publication E-Mailed
Dec 5, 2012
Law Office Publication Review Completed
Dec 5, 2012
Assigned To Lie
Nov 21, 2012
Approved For Pub - Principal Register
Nov 21, 2012
Examiner's Amendment Entered
Nov 21, 2012
Notification Of Examiners Amendment E-Mailed
Nov 21, 2012
Examiners Amendment E-Mailed
Nov 21, 2012
Examiners Amendment -Written
Nov 20, 2012
Teas/Email Correspondence Entered
Nov 20, 2012
Correspondence Received In Law Office
Nov 20, 2012
Teas Request For Reconsideration Received
Jun 27, 2012
Notification Of Final Refusal Emailed
Jun 27, 2012
Final Refusal E-Mailed
Jun 27, 2012
Final Refusal Written
May 30, 2012
Teas/Email Correspondence Entered
May 29, 2012
Correspondence Received In Law Office
May 29, 2012
Teas Response To Office Action Received
Dec 18, 2011
Refusal Processed By Ib
Nov 30, 2011
Non-Final Action Mailed - Refusal Sent To Ib
Nov 30, 2011
Refusal Processed By Mpu
Nov 30, 2011
Non-Final Action (Ib Refusal) Prepared For Review
Nov 29, 2011
Non-Final Action Written
Nov 21, 2011
Assigned To Examiner
Oct 8, 2011
Application Filing Receipt Mailed
Oct 4, 2011
New Application Office Supplied Data Entered In Tram
Sep 30, 2011
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
